rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex (Q50890848)

24 March 2018

title

rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex (English)

1 reference

24 March 2018

1 reference

2

Felipe Fregni

1 reference

24 March 2018

4

Paulo S Boggio

1 reference

24 March 2018

14

Edson Amaro

1 reference

24 March 2018

Sergio P Rigonatti

11

object named as

Sergio P Rigonatti

1 reference

24 March 2018

Marco Antônio Marcolin

10

object named as

Marco Antonio Marcolin

1 reference

24 March 2018

author name string

Ellison Fernando Cardoso

1

1 reference

24 March 2018

Fernanda Martins Maia

3

1 reference

24 March 2018

Martin Luis Myczkowski

5

1 reference

24 March 2018

Karen Coracini

6

1 reference

24 March 2018

Adriana Lopes Vieira

7

1 reference

24 March 2018

Luciano M Melo

8

1 reference

24 March 2018

João R Sato

9

1 reference

24 March 2018

Antonio Cesário Cruz

12

1 reference

24 March 2018

Egberto Reis Barbosa

13

1 reference

24 March 2018

publication date

21 August 2007

1 reference

24 March 2018

The International Journal of Neuropsychopharmacology

published in

1 reference

24 March 2018

volume

11

1 reference

24 March 2018

issue

2

1 reference

24 March 2018

page(s)

173-183

1 reference

24 March 2018

Limbic-frontal circuitry in major depression: a path modeling metanalysis.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Transcranial magnetic stimulation: a novel antidepressive strategy?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Depression in Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Wavelets and statistical analysis of functional magnetic resonance images of the human brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Neurobiology of emotion perception II: Implications for major psychiatric disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Neurobiology of emotion perception I: The neural basis of normal emotion perception

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Spatiotemporal wavelet resampling for functional neuroimaging data

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Generic brain activation mapping in functional magnetic resonance imaging: A nonparametric approach

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Changes in regional cerebral blood flow on recovery from depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Drug treatment of depression in the 1990s. An overview of achievements and future possibilities

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Parkinson's disease from WHO perspective and a public health point of view

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Human neural systems for face recognition and social communication

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Antidepressant drug treatment modifies the neural processing of nonconscious threat cues

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Mechanisms and the current state of transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Hemispheric asymmetries of affective processing as determined by the Minnesota Multiphasic Personality Inventory

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

The involvement of the "fusiform face area" in processing facial expression.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Emotional Behavior and Hemispheric Side of the Lesion

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Patchy organization and asymmetric distribution of the neural correlates of face processing in monkey inferotemporal cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Psychiatric complications in Parkinson disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

A sham-controlled trial of a 5-day course of repetitive transcranial magnetic stimulation of the unaffected hemisphere in stroke patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Recognition and treatment of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Immediate placebo effect in Parkinson's disease--is the subjective relief accompanied by objective improvement?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Depression in Parkinson's disease. Pharmacological characteristics and treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Transcranial magnetic stimulation downregulates beta-adrenoreceptors in rat cortex

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Dopamine modulates the response of the human amygdala: a study in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

The neural substrates of affective processing in depressed patients treated with venlafaxine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

Differences between depressed and nondepressed individuals in the recognition of and response to facial emotional cues.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007961

7 January 2021

10.1017/S1461145707007961

Identifiers

DOI

1 reference

24 March 2018

1 reference

24 March 2018